Morgan CJ; Das RK; Joye A; Curran HV; Kamboj SK
Clinical Psychopharmacology Unit, University College London, London, UK. c.morgan@ucl.ac.uk
“These preliminary data, combined with the strong preclinical rationale for use of this compound, suggest CBD to be a potential treatment for nicotine addiction that warrants further exploration.”
Full Abstract:
http://www.medscape.com/medline/abstract/23685330